Skip to main content
Equibles
BBIO logo

BBIO · BridgeBio Pharma, Inc. · Analyst Estimates

Track BBIO — free

Use BBIO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BBIO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$68.15 -0.41 (-0.60%) At close · Oct 26
Russell 1000 member Rebalance outlook locked
Market Cap
$13.32B
Shares
195.49M
Volume · Oct 26 2.06M Avg daily vol (3M) 2.47M

Analyst Estimates

Compare analyst forecasts for BridgeBio Pharma, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-22 19:15 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-3.01
-2.62
-1.88
8
-2.60
-2.58
-2.68
-2.14
0
8
0
0
Revenue
USD
Publication date not stated
970.30M
1.04B
1.12B
20
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-2.42
-0.22
1.31
6
0.029
0.027
0.15
0.59
0
0
1
1
Revenue
USD
Publication date not stated
1.48B
1.67B
1.88B
19
 — — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.66
-0.56
-0.40
6
-0.63
-0.63
-0.67
-0.45
0
0
1
1
Revenue
USD
Publication date not stated
255.00M
295.75M
347.40M
18
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.63
-0.40
0.13
5
-0.44
-0.44
-0.53
-0.25
1
1
0
0
Revenue
USD
Publication date not stated
277.00M
306.65M
396.83M
16
 — — — — — — — —
Key facts CIK 1743881 CUSIP 10806X102 13F (30d) 62 filings 58 filers Visit website Investor relations